International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-2 doi: 10.5281/zenodo.7847867
Original Article
Efficacy of Ultrasound Guided Continuous Transverse Abdominis Plane Block for Lower Abdominal Surgeries
 ,
 ,
Published
April 20, 2023
Abstract
Introduction: The effect of a single transverse abdominis plane(TAP) block is not durable, and its analgesic efficacy lasts less than 24 hr. Thus, continuous transverse abdominis plane block by placing the catheter into the transverse abdominal plane and infusing local anaesthetic drugs continuously or intermittently through the catheter were used. This study evaluates the efficacy of ultrasound guided continuous TAP block in comparison with conventional TAP block for lower abdominal surgeries. Material and methods: There were 60 patients in the study, allocated to continuous TAP and control groups. parameters measured were pain scores on a visual analog scale (VAS) at various time interval. patients satisfaction were recorded in continuous TAP block group along with its complications related to the block. Results: Preoperative pain score was 1 for 2 patients of continuous TAP group and 6 patients of conventional block group. Preoperative pain score was 2 for 13 patients of continuous TAP group and11 patients of conventional block group. Preoperative pain score was 3 for 15 patients of continuous TAP group and 13 patients of conventional block group. Conclusion: The anatomical approach of Continuous TAP block is also very safe and reasonably effective. Ultrasound-guided Continuous TAP block reduced postoperative rest and movement pain and analgesic requirements after lower abdominal surgeries and was more effective than conventional block.
Recommended Articles
Loading Image...
Volume-4, Issue-2
Citations
109 Views
399 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved